Global AI-based Embryo Decision Support Tools Market Research Report 2025

Publication ID:

PB503250420

Publication Date:

March 6, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

The global market for AI-based Embryo Decision Support Tools was valued at US$ 43.2 million in the year 2024 and is projected to reach a revised size of US$ 61.3 million by 2031, growing at a CAGR of 5.0% during the forecast period.
Embryo Decision Support Tools are AI-driven or algorithm-based systems that assist embryologists and fertility specialists in selecting the best embryos for implantation during in vitro fertilization (IVF). These tools enhance accuracy, objectivity, and efficiency in embryo grading and selection, increasing the chances of successful pregnancy.
North American market for AI-based Embryo Decision Support Tools is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for AI-based Embryo Decision Support Tools is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for AI-based Embryo Decision Support Tools in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of AI-based Embryo Decision Support Tools include Vitrolife, Genea BIOMEDX, MIM Fertility, Alife Health, Fairtility, ASTEC CO., Ltd, Care Fertility, Cycle Clarity, KritiKal Solutions, ImVitro, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for AI-based Embryo Decision Support Tools, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI-based Embryo Decision Support Tools.
The AI-based Embryo Decision Support Tools market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI-based Embryo Decision Support Tools market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI-based Embryo Decision Support Tools companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Vitrolife
Genea BIOMEDX
MIM Fertility
Alife Health
Fairtility
ASTEC CO., Ltd
Care Fertility
Cycle Clarity
KritiKal Solutions
ImVitro
Segment by Type
Web-based
Cloud-based
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI-based Embryo Decision Support Tools company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI-based Embryo Decision Support Tools Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Web-based
1.2.3 Cloud-based
1.3 Market by Application
1.3.1 Global AI-based Embryo Decision Support Tools Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI-based Embryo Decision Support Tools Market Perspective (2020-2031)
2.2 Global AI-based Embryo Decision Support Tools Growth Trends by Region
2.2.1 Global AI-based Embryo Decision Support Tools Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 AI-based Embryo Decision Support Tools Historic Market Size by Region (2020-2025)
2.2.3 AI-based Embryo Decision Support Tools Forecasted Market Size by Region (2026-2031)
2.3 AI-based Embryo Decision Support Tools Market Dynamics
2.3.1 AI-based Embryo Decision Support Tools Industry Trends
2.3.2 AI-based Embryo Decision Support Tools Market Drivers
2.3.3 AI-based Embryo Decision Support Tools Market Challenges
2.3.4 AI-based Embryo Decision Support Tools Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI-based Embryo Decision Support Tools Players by Revenue
3.1.1 Global Top AI-based Embryo Decision Support Tools Players by Revenue (2020-2025)
3.1.2 Global AI-based Embryo Decision Support Tools Revenue Market Share by Players (2020-2025)
3.2 Global Top AI-based Embryo Decision Support Tools Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AI-based Embryo Decision Support Tools Revenue
3.4 Global AI-based Embryo Decision Support Tools Market Concentration Ratio
3.4.1 Global AI-based Embryo Decision Support Tools Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI-based Embryo Decision Support Tools Revenue in 2024
3.5 Global Key Players of AI-based Embryo Decision Support Tools Head office and Area Served
3.6 Global Key Players of AI-based Embryo Decision Support Tools, Product and Application
3.7 Global Key Players of AI-based Embryo Decision Support Tools, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AI-based Embryo Decision Support Tools Breakdown Data by Type
4.1 Global AI-based Embryo Decision Support Tools Historic Market Size by Type (2020-2025)
4.2 Global AI-based Embryo Decision Support Tools Forecasted Market Size by Type (2026-2031)
5 AI-based Embryo Decision Support Tools Breakdown Data by Application
5.1 Global AI-based Embryo Decision Support Tools Historic Market Size by Application (2020-2025)
5.2 Global AI-based Embryo Decision Support Tools Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America AI-based Embryo Decision Support Tools Market Size (2020-2031)
6.2 North America AI-based Embryo Decision Support Tools Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America AI-based Embryo Decision Support Tools Market Size by Country (2020-2025)
6.4 North America AI-based Embryo Decision Support Tools Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI-based Embryo Decision Support Tools Market Size (2020-2031)
7.2 Europe AI-based Embryo Decision Support Tools Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe AI-based Embryo Decision Support Tools Market Size by Country (2020-2025)
7.4 Europe AI-based Embryo Decision Support Tools Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI-based Embryo Decision Support Tools Market Size (2020-2031)
8.2 Asia-Pacific AI-based Embryo Decision Support Tools Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific AI-based Embryo Decision Support Tools Market Size by Region (2020-2025)
8.4 Asia-Pacific AI-based Embryo Decision Support Tools Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI-based Embryo Decision Support Tools Market Size (2020-2031)
9.2 Latin America AI-based Embryo Decision Support Tools Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America AI-based Embryo Decision Support Tools Market Size by Country (2020-2025)
9.4 Latin America AI-based Embryo Decision Support Tools Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI-based Embryo Decision Support Tools Market Size (2020-2031)
10.2 Middle East & Africa AI-based Embryo Decision Support Tools Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa AI-based Embryo Decision Support Tools Market Size by Country (2020-2025)
10.4 Middle East & Africa AI-based Embryo Decision Support Tools Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Vitrolife
11.1.1 Vitrolife Company Details
11.1.2 Vitrolife Business Overview
11.1.3 Vitrolife AI-based Embryo Decision Support Tools Introduction
11.1.4 Vitrolife Revenue in AI-based Embryo Decision Support Tools Business (2020-2025)
11.1.5 Vitrolife Recent Development
11.2 Genea BIOMEDX
11.2.1 Genea BIOMEDX Company Details
11.2.2 Genea BIOMEDX Business Overview
11.2.3 Genea BIOMEDX AI-based Embryo Decision Support Tools Introduction
11.2.4 Genea BIOMEDX Revenue in AI-based Embryo Decision Support Tools Business (2020-2025)
11.2.5 Genea BIOMEDX Recent Development
11.3 MIM Fertility
11.3.1 MIM Fertility Company Details
11.3.2 MIM Fertility Business Overview
11.3.3 MIM Fertility AI-based Embryo Decision Support Tools Introduction
11.3.4 MIM Fertility Revenue in AI-based Embryo Decision Support Tools Business (2020-2025)
11.3.5 MIM Fertility Recent Development
11.4 Alife Health
11.4.1 Alife Health Company Details
11.4.2 Alife Health Business Overview
11.4.3 Alife Health AI-based Embryo Decision Support Tools Introduction
11.4.4 Alife Health Revenue in AI-based Embryo Decision Support Tools Business (2020-2025)
11.4.5 Alife Health Recent Development
11.5 Fairtility
11.5.1 Fairtility Company Details
11.5.2 Fairtility Business Overview
11.5.3 Fairtility AI-based Embryo Decision Support Tools Introduction
11.5.4 Fairtility Revenue in AI-based Embryo Decision Support Tools Business (2020-2025)
11.5.5 Fairtility Recent Development
11.6 ASTEC CO., Ltd
11.6.1 ASTEC CO., Ltd Company Details
11.6.2 ASTEC CO., Ltd Business Overview
11.6.3 ASTEC CO., Ltd AI-based Embryo Decision Support Tools Introduction
11.6.4 ASTEC CO., Ltd Revenue in AI-based Embryo Decision Support Tools Business (2020-2025)
11.6.5 ASTEC CO., Ltd Recent Development
11.7 Care Fertility
11.7.1 Care Fertility Company Details
11.7.2 Care Fertility Business Overview
11.7.3 Care Fertility AI-based Embryo Decision Support Tools Introduction
11.7.4 Care Fertility Revenue in AI-based Embryo Decision Support Tools Business (2020-2025)
11.7.5 Care Fertility Recent Development
11.8 Cycle Clarity
11.8.1 Cycle Clarity Company Details
11.8.2 Cycle Clarity Business Overview
11.8.3 Cycle Clarity AI-based Embryo Decision Support Tools Introduction
11.8.4 Cycle Clarity Revenue in AI-based Embryo Decision Support Tools Business (2020-2025)
11.8.5 Cycle Clarity Recent Development
11.9 KritiKal Solutions
11.9.1 KritiKal Solutions Company Details
11.9.2 KritiKal Solutions Business Overview
11.9.3 KritiKal Solutions AI-based Embryo Decision Support Tools Introduction
11.9.4 KritiKal Solutions Revenue in AI-based Embryo Decision Support Tools Business (2020-2025)
11.9.5 KritiKal Solutions Recent Development
11.10 ImVitro
11.10.1 ImVitro Company Details
11.10.2 ImVitro Business Overview
11.10.3 ImVitro AI-based Embryo Decision Support Tools Introduction
11.10.4 ImVitro Revenue in AI-based Embryo Decision Support Tools Business (2020-2025)
11.10.5 ImVitro Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Vitrolife
Genea BIOMEDX
MIM Fertility
Alife Health
Fairtility
ASTEC CO., Ltd
Care Fertility
Cycle Clarity
KritiKal Solutions
ImVitro

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂